Lift Biosciences
Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.
About
LIfT BioSciences is a UK-based biotechnology company developing first-in-class, off-the-shelf neutrophil-lineage cell therapies called Immunomodulatory Alpha Neutrophils (IMANs). These therapies are designed to directly kill tumor cells and re-ignite anti-tumor immunity in cancer patients with solid tumors. LIfT BioSciences is preparing for its first-in-human clinical study to assess IMANs' safety and efficacy in patients with advanced cervical and head & neck cancers. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does Lift Biosciences do?
Lift Biosciences is a Biotech company that offers Software | hardware | services. Teams look it up for MedTech, HealthTech, Drug Discovery. It is based in Cambridge, United Kingdom and was founded in 2019. Public records show about 22 people and $18M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Lift Biosciences raised?
Lift Biosciences has raised a total of $18M in funding.
Where is Lift Biosciences headquartered?
Lift Biosciences is headquartered in Cambridge, United Kingdom.
When was Lift Biosciences founded?
Lift Biosciences was founded in 2019.
What industry does Lift Biosciences operate in?
Lift Biosciences operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials.
How many employees does Lift Biosciences have?
Lift Biosciences has approximately 22 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.